ESTADO ACTUAL DE LOS ESTUDIOS

Transcripción

1 ESTADO ACTUAL DE LOS ESTUDIOS ARTÍCULOS ACEPTADOS: 13 Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Dr. V. Torrente Segarra Juvenile and adult onset Systemic Lupus Erythematosus: a comparative study in a large cohort from the spanish society of rheumatology lupus registry (RELESSER). Dr. V. Torrente Segarra. Clin and Exp Rheumatol Incidence, associated factors and clinical impact of severe infections in a large multicentric cohort of patients with Systemic Lupus Erythematosus. Dr. I. Rúa-Figueroa. Semin Arthritis Rheum Systemic Lupus Erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort. Dra. A. Riveros Frutos. Lupus Comorbidities in patients with Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A comparative registries-based study. Dr. I. Rúa-Figueroa. Arthritis Care Res (Hoboken) Relationship between damage clustering and mortality in Systemic Lupus Erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry. Dr. J.M. Pego Reigosa. Rheumatology (Oxford). 2016

2 Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER). Dra. M. Galindo Izquierdo. Medicine (Baltimore) Fibromyalgia prevalence and related factors in a large registry of patients with Systemic Lupus Erythematosus. Dr. V. Torrente Segarra. Clin Exp Rheumatol Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry. Dr. A. Fernández-Nebro. Medicine (Baltimore) Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort. Dr. L. Inês. Arthritis Care Res (Hoboken) Comprehensive description of clinical characteristics of a large Systemic Lupus Erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences. Dr. I Rúa-Figueroa. Medicine (Baltimore) Analysis of disease activity and response to treatment in a large Spanish cohort of patients with Systemic Lupus Erythematosus. Dr. J.M. Pego Reigosa. Lupus National registry of patients with Systemic Lupus Erythematosus of the Spanish Society of Rheumatology: objectives and methodology. Dr. I Rúa-Figueroa. Reumatol Clin

3 ARTÍCULOS ENVIADOS A REVISTAS: 4 All the hispanics are not equal. The severity and activity of patients with SLE is higher in mestizos latin american vs. european caucasian. Lessons from RELESSER. Autora principal: Dra. B. Hernández Cruz. Clinical and Experimental Rheumatology. Primary Respiratory Disease in Patients with Systemic Lupus Erythematosus: Data from the Spanish Rheumatology Society Lupus Registry (RELESSER) Cohort. Autor principal: Dr. J. Narváez García. Seminars in Arthritis and Rheumatism. Bacteriemia in Systemic Lupus Erythematosus patients from RELESSER registry: risk factor, clinical and microbiological charasteristisc and outcome. Autor principal: Dr. I. Rúa-Figueroa. Journal of Rheumatology. Development and validation of a score to predict the risk of severe infection in Systemic Lupus Erythematosus. Autora principal: Dra. B. Tejera Segura. Arthritis Care Research. ESTUDIOS EN DESARROLLO: 12 Lupus Impact Tracker Validation in a Large European Spanish Lupus Registry Cohort. Dra. Meenakshi Jolly. Idiopathic Thrombocytopenic Purpura from Systemic Lupus Erythematosus registry from the Spanish Society of Rheumatology (RELESSER) Dra. A. Lois Iglesias

4 Neoplasia in patients with Systemic Lupus Erythematosus in Spain: RELESSER registry data Dra. T. Cobo Ibáñez. Chronological analysis of damage accrual in Systemic Lupus Erythematosus patients from the spanish registry (RELESSER) Dr. J.M. Pego Reigosa. Late Onset Systemic Lupus Erythematosus: A Different Disease Subset? Dra. A. Riveros Frutos. Mycobacterial infection in Systemic Lupus Erythematosus: clinical significance and associated factors. Data from the registry of patients with SLE of the Spanish Society of Rheumatology (RELESSER) Dr. J.M. Pego Reigosa. Análisis de Infecciones Graves en población LES de inicio en edad infantil. Dr. V. Torrente Segarra. Poliautoinmunidad y síndromes de solapamiento en el LES Dr. A. Fernández Nebro.

5 Estudio de la influencia del clima en las lesiones cutáneas en el registro RELESSER. Dr. R. Menor Almagro. Análisis síndrome antifosfolípido secundario a lupus eritematoso. Estudio descriptivo, caracterización de cohorte nacional. Dr. V. Martínez-Taboada. Comparar la comorbilidad cardiovascular (CV) y factores de riesgo CV en dos poblaciones con patología reumática crónica bien diferenciadas: una con AR, EA, AP y otra con LES en España. Dr. S. Castañeda Sanz. Lupus eritematoso sistémico y enfermedad inflamatoria intestinal, correlación o causalidad? Dra. B. Tejera Segura. OBTENCIÓN BECA FIS 2017: Caracterización de los estados de baja actividad y remisión del Lupus Eritematoso Sistémico por expertos en la enfermedad: estudio de cohortes, multicéntrico y prospectivo IP: Dr. J.M. Pego Reigosa COMUNICACIONES A CONGRESOS: 72 Congreso Nacional SER: 23

6 o 2018: 2 (1 oral) o 2017: 5 (orales 2) o 2016: 4 (orales 3) o 2015: 3 (orales 3) o 2014: 5 (orales 2) o 2012: 4 (orales 2) ACR/ARHP Annual Meeting - American College of Rheumatology: 14 o 2018: 4 o 2017: 3 o 2016: 1 o 2015: 3 o 2014: 2 o 2012: 1 European League Against Rheumatology Annual Congress: 24 o 2018: 3 o 2017: 4 (oral 1) o 2016: 4 o 2015: 4 o 2014: 6 o 2012: 3 European Lupus Meeting: 11 o 2018: 5 (2 orales) o 2016: 3 (orales 2) o 2013: 3